# Paragon Swiss – FDA Inspection, Jan 12, 2024

Source: https://www.keypedia.com/records/fda_inspections/paragon-swiss/e7d59826-eb1c-41a3-aa9a-043493e3ed3d
Source feed: FDA_Inspections

> FDA inspection 1227806 of Paragon Swiss, January 12, 2024. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1227806
- Company Name: Paragon Swiss
- Inspection Date: 2024-01-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: New Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: San Francisco District Office
- Citation Count: 3

## Related Documents

- [FDA Inspection 1324156 - 2026-06-12](https://www.keypedia.com/records/fda_inspections/paragon-swiss/60f19972-48b5-4712-a442-e3b3a7bbf66e)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/saied-a-asbagh/215bfa90-995f-4310-baf3-cd9d37639b7b)

Company: https://www.keypedia.com/companies/paragon-swiss/4731e134-17ce-4216-bf50-d696e3dc3256

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df